Literature DB >> 18835029

Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?

Ariel Ruiz i Altaba1.   

Abstract

Hedgehog (HH)-GLI signaling is a developmental patterning pathway used by many tumors for bulk proliferation that has been shown also to regulate cancer stem cell self-renewal and survival. Surprisingly, a recent study by Yauch et al. (2008) proposes that HH-GLI signaling acts only on the tumor stroma. The mode of action of HH-GLI signaling in cancer may shape the development of therapeutic antagonists.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18835029     DOI: 10.1016/j.ccr.2008.09.007

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  31 in total

1.  Ski modulate the characteristics of pancreatic cancer stem cells via regulating sonic hedgehog signaling pathway.

Authors:  Libin Song; Xiangyuan Chen; Song Gao; Chenyue Zhang; Chao Qu; Peng Wang; Luming Liu
Journal:  Tumour Biol       Date:  2016-10-12

2.  Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity.

Authors:  Samer Singh; Zhiqiang Wang; Dennis Liang Fei; Kendall E Black; John A Goetz; Robert Tokhunts; Camilla Giambelli; Jezabel Rodriguez-Blanco; Jun Long; Ethan Lee; Karoline J Briegel; Pablo A Bejarano; Ethan Dmitrovsky; Anthony J Capobianco; David J Robbins
Journal:  Cancer Res       Date:  2011-05-12       Impact factor: 12.701

3.  Expression of Hedgehog ligand and signal transduction components in mutually distinct isocitrate dehydrogenase mutant glioma cells supports a role for paracrine signaling.

Authors:  Sunday A Abiria; Thomas V Williams; Alexander L Munden; Vandana K Grover; Ato Wallace; Christopher J Lundberg; J Gerardo Valadez; Michael K Cooper
Journal:  J Neurooncol       Date:  2014-05-28       Impact factor: 4.130

4.  Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.

Authors:  Adam Steg; Hope M Amm; Zdenek Novak; Andra R Frost; Martin R Johnson
Journal:  Cancer Biol Ther       Date:  2010-11-01       Impact factor: 4.742

5.  Dual Phosphorylation of suppressor of fused (Sufu) by PKA and GSK3beta regulates its stability and localization in the primary cilium.

Authors:  Yan Chen; Shen Yue; Lu Xie; Xiao-hong Pu; Tian Jin; Steven Y Cheng
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

6.  Smoothened antagonists reverse taxane resistance in ovarian cancer.

Authors:  Adam D Steg; Ashwini A Katre; Kerri S Bevis; Angela Ziebarth; Zachary C Dobbin; Monjri M Shah; Ronald D Alvarez; Charles N Landen
Journal:  Mol Cancer Ther       Date:  2012-05-02       Impact factor: 6.261

Review 7.  Hedgehog signalling in breast cancer.

Authors:  Maria Kasper; Viljar Jaks; Marie Fiaschi; Rune Toftgård
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

Review 8.  Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals.

Authors:  Barbara Stecca; Ariel Ruiz i Altaba
Journal:  J Mol Cell Biol       Date:  2010-01-17       Impact factor: 6.216

9.  Sonic Hedgehog pathway activity in prostate cancer.

Authors:  Olga Bragina; Natalja Njunkova; Svetlana Sergejeva; Lilian Järvekülg; Priit Kogerman
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

10.  GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.

Authors:  Junsheng Fu; Mariana Rodova; Sanjit K Roy; Jay Sharma; Karan P Singh; Rakesh K Srivastava; Sharmila Shankar
Journal:  Cancer Lett       Date:  2012-11-28       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.